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Summary
The binding surface on CD4 for the HIV-1 gp120 enve-
lope glycoprotein has been transplanted previously
onto a scorpion-toxin scaffold. Here, we use X-ray
crystallography to characterize atomic-level details of
gp120 with this transplant, CD4M33. Despite known
envelope flexibility, the conformation of gp120 in-
duced by CD4M33 was so similar to that induced by
CD4 that localized measures were required to distin-
guish ligand-induced differences from lattice varia-
tion. To investigate relationships between structure,
function, and mimicry, an F23 analog of CD4M33 was
devised. Structural and thermodynamic analyses
showed F23 to be a better molecular mimic of CD4
than CD4M33. F23 also showed increased neutraliza-
tion breadth, against diverse isolates of HIV-1, HIV-2,
and SIVcpz. Our results lend insight into the stability*Correspondence: pdkwong@nih.govof the CD4 bound conformation of gp120, define mea-
sures that quantify molecular mimicry as a function
of evolutionary distance, and suggest how such eval-
uations might be useful in developing mimetic antag-
onists with increased neutralization breadth.
Introduction
The first step in the entry of human immunodeficiency
virus type 1 (HIV-1) involves the binding of the viral
gp120 envelope glycoprotein to the CD4 receptor on
the surface of a new potential host cell (reviewed in
Wyatt and Sodroski, 1998). Biochemical and thermo-
dynamic studies show that this binding induces sub-
stantial conformational changes in gp120 (Moore et al.,
1990; Myszka et al., 2000). Crystal structures of CD4
(Ryu et al., 1990; Wang et al., 1990; Wu et al., 1997), of
gp120 in complex with CD4 (Kwong et al., 1998, 2000),
and most recently of unliganded gp120 (Chen et al.,
2005) define the conformational change in detail. CD4
remains essentially fixed throughout the binding reac-
tion. In contrast, gp120 undergoes a remarkable refold-
ing, with roughly half of its core secondary structure
rearranging; when modeled into the context of the viral
spike, these rearrangements move select structural ele-
ments over 40 Å (Chen et al., 2005).
The precise interface of CD4 with gp120 involves a
mostly contiguous surface contributed by three se-
quence segments of CD4: residues 31–35, residues 40–
48, and residues 58–64 (Figure 1A). Of these, residues
40–48, which form part of the CDR2-like antiparallel β
strands of CD4, are the most important and account for
40% of the total contact surface (Kwong et al., 1998;
Moebius et al., 1992; Sweet et al., 1991).
The extensive structural information combined with
the inability to date of small molecule screening to
identify effective CD4-mimetic antagonists has spurred
structure-based efforts. These range from chemical
mimicry of the CDR2-like loop (Chen et al., 1992) to
phage display selection (Choi et al., 2001; Ferrer and
Harrison, 1999) and scaffold transplantation (Martin
and Vita, 2000). In general, transplantation of a confor-
mational binding site to a smaller scaffold is a difficult
endeavor (reviewed in Fernandez-Carneado et al., 2000
and Martin and Vita, 2000). The gp120 interface is par-
ticularly daunting in that it is relatively large, contains
unusual cavities, and is composed of primarily back-
bone interactions, arranged by gp120 refolding (Kwong
et al., 1998, 2000; Myszka et al., 2000). Nonetheless,
attempts to transfer the CD4-gp120 binding surface
have met with success, especially with the scorpion
toxin scyllatoxin, a 31 amino acid protein with three di-
sulfide bonds holding together an α helix and two anti-
parallel β strands (Martin et al., 2003; Vita et al., 1999).
These efforts produced CD4M33, which showed bind-
ing affinities with select isolates comparable to CD4
(Martin et al., 2003). Its success prompted a number
of questions: in light of the conformational flexibility of
gp120, what conformation does CD4M33 recognize?
Structure
756Figure 1. Mimicry of CD4 by CD4M33
(A) Ribbon diagrams of core YU2 gp120 (green) are shown binding to CD4 (left) and CD4M33 (right). In this orientation, the four-stranded
bridging sheet of gp120 is positioned directly to the left of CD4, the inner domain is positioned above it, and the outer domain is positioned
to the right. CD4M33 is shown in purple, and CD4 is shown in gray, except for the three main regions that contribute to binding, which are
colored orange-yellow (residues 40–48) and black (residues 31–35 and 58–64).
(B) Close-up view of the CD4-gp120 “hotspot.” The orientation and colors are the same as in (A), except that oxygen atoms are colored red
and nitrogen atoms are colored blue. The unusual interfacial cavity (red) between CD4 and gp120 is shown in the left panel. The right panel
shows the biphenyl side chain of CD4M33 reaching into the heart of gp120. Density (Fo − Fc; 3 σ; purple) is shown from a simulated annealing
omit map in which the entire CD4M33 had been removed. Distances (Å) are shown for four hydrogen bonds.
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757medium-resolution (1.50–2.30 Å) crystal structures ofto the β15 strand of gp120 in a manner similar to the
(C) Close-up view of an intermolecular salt bridge. The left panel shows the double hydrogen bond made by CD4 Arg 59. The right panel
displays the two independent CD4M33 complexes of the P21 asymmetric unit (purple and gray), only one of which makes a salt bridge
with gp120.
(D) Contact surface on gp120. The orientation shown is rotated 90° about a horizontal axis from that shown in (A) and (B). In this orientation,
the virus would be located toward the top of the page, and the target cell would be located toward the bottom. The left panel shows the
contact surface of CD4, colored green, with yellow highlighting the portion of the surface contacted by CD4 residues 40–47. The right panel
shows the contact surface of CD4M33 in green, with purple highlighting the portion of the surface contributed by CD4M33 residues 20–27.
The portion of the contact surface unique to CD4M33 (primarily where the biphenyl moiety reaches into gp120) is highlighted in red.How similar is this to the conformation induced by
CD4? To what degree is CD4M33 a molecular mimic
of CD4?
Here, we use X-ray crystallography to address these
questions. Our results represent the first in-depth
atomic-level description of the successful transplanta-
tion of a complex binding surface to a smaller scaffold.
We use the opportunity to address questions of molec-
ular mimicry, to explore how evolutionary diversity may
affect such considerations, and to discuss tradeoffs be-
tween overall neutralization breadth and specific po-
tency against target subsets.
Results
CD4M33 Structure in Complex with HIV-1 Core gp120
To define the CD4M33 mimicry at the atomic level, we
crystallized and solved the structure of CD4M33 in
complex with core gp120 from the primary HIV-1 isolate
YU2 and the antigen binding fragment (Fab) of the 17b
antibody (Figure 1). The crystals were space group P21
(a = 51.6 Å, b = 157.0 Å, c = 108.9 Å, β = 93.5°) with two
ternary complexes in the asymmetric unit. The struc-
ture was solved by using molecular replacement with
the previously determined ternary structure (Kwong et
al., 2000) of core YU2 gp120 in complex with CD4 and
Fab 17b. After rigid-body refinement of the gp120 and
Fab 17b orientations, electron density for CD4M33 was
clearly defined, and this was fitted, starting with the
NMR structure of the free CD4M33 (P.B. and C.R., un-
published data). Refinement with 20–2.75 Å data pro-
duced an R value of 20.2% and an Rfree of 27.5% (Ta-
ble 1).
The overall structures of core gp120 in the Fab 17b
ternary complexes with CD4M33 and CD4 were similar.
The primary structural differences were related to lat-
tice interactions at the core N terminus: in the CD4
complex, a lattice contact with a symmetry-related 17b
Fab disrupts the first three residues; in the CD4M33
complex, the first six residues are involved in a lattice
interaction with the inner domain of a symmetry-related
gp120 molecule. There were also differences at the site
of V1/V2 loop truncation and in the V4 loop, which was
disordered in the mimetic ternary structure. Superposi-
tions excluding these regions showed overall Cα root
mean square (rms) deviations of 0.89/0.88 Å (the two
numbers are from the two independent CD4M33 com-
plexes in the P21 asymmetric unit). These rms devia-
tions are comparable to the Cα rms deviation (0.87 Å)
between the CD4:gp120:17b ternary complexes of the
different gp120 isolates, YU2 and HXBc2.
The antiparallel β strands of CD4M33 hydrogen bondCDR2-like loop of CD4 (Figure 1B). Superposition of the
main chain atoms of residues 22–26 of CD4M33 and
residues 42–46 of CD4 produced rms deviations of
0.43/0.49 Å and of 0.93/1.06 Å for the CDR2-like region
(residues 16–27 for CD4M33 and residues 36–47 for
CD4). Four hydrogen bonds between residues 22–26
and gp120 (equivalent to CD4 residues 42–46), one
from the side chain oxygen of Ser22 and three from the
main chain atoms of residues 24 and 26, are conserved
in the CD4M33:YU2core structure. The stereochemistry
of these bonds is remarkably similar, especially for the
intermolecular antiparallel strands (Figure 1B).
The mimicry by CD4M33 of the two other sequence
segments of CD4 (residues 31–35 and 58–64) was less
successful. The β strands of CD4M33 are shorter than
those of the CDR2-like loop of CD4 and, consequently,
do not extend to make contacts like residues 31–35 of
CD4. Arg9 of CD4M33, meanwhile, only partially mimics
the important Arg59 contact of CD4; two conformations
were observed, only one of which makes a salt bridge
with Asp368 of gp120 (Figure 1C). Other portions of the
mimetic, however, bind to the surface otherwise occu-
pied by 58–64 of CD4; for example, thiopropionic acid
at the N terminus of CD4M33 contacts gp120 at a sur-
face that interacts with CD4 residues 59 and 62.
The contact surface between CD4M33 and gp120 is
449/475 Å2 for CD4M33, approximately 55% of the CD4
interface. A primary “hotspot” of interaction (Clackson
and Wells, 1995) in the gp120 interface involves Phe43
of CD4, which binds at the nexus of the inner, outer,
and bridging sheet domains of gp120, where an un-
usual interfacial cavity resides (Kwong et al., 1998) (Fig-
ure 1B). In CD4M33, a biphenyl side chain was de-
signed to not only mimic Phe43, but to protrude and fill
the CD4-gp120 interfacial cavity. This biphenyl group
(residue 23 of CD4M33) contributes 168/170 Å2 (37%)
of the total area, with roughly 80 Å2 contributed by its
second ring, where it reaches into the heart of gp120.
The footprints of the contact surface made by residues
20–27 of CD4M33 and residues 40–47 of CD4 are very
similar (Figure 1D). In the CD4M33:YU2core complex,
this region accounts for more than 80% of the interface.
We attribute the high affinity of CD4M33, despite
making only half the contacts as CD4, to filling the CD4-
gp120 interfacial cavity with the second ring of the un-
natural biphenyl side chain. However, biphenyl groups
are relatively rigid, with limited flexibility along their
long axes and dihedral constraints between their two
rings (Dzyabchenko and Scheraga, 2004). The ob-
served ring-ring dihedrals were 38°/40° for CD4M33 in
the CD4M33:YU2core complexes (the two angles spec-
ified here are the observed angles for the two indepen-
dent CD4M33 molecules in the asymmetric unit). For
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758Table 1. X-Ray Crystallographic Data and Refinement
Data Collection
Crystal F23/core YU2 gp120/Fab 17b CD4M33/core YU2 gp120/Fab 17b
Space group P21 P21
Molecules per ASU 2 2
Wavelength, Å 1.00 1.00
Unit cell dimensions a = 51.6 Å, b = 157.0 Å, c = 108.9 Å, β = 93.5° a = 51.5 Å, b = 157.8 Å, c = 109.9 Å, β = 93.5°
Completeness, %a 95.0 (69.2) 91.8 (46.4)
Number of reflectionsb 289,011 (82,351) 207,374 (41,666)
Redundancya 3.5 (2.2) 5.0 (2.1)
I/σa 8.8 (1.3) 8.2 (1.5)
Rsym, %a,c 12.1 (34.0) 12.6 (27.8)
Refinement Statistics (|F| > 0 σ)
Resolution, Å 20–2.20 20–2.75
Number of reflections 77,539 39,944
Rcrys, %a,d 20.9 (29.5) 20.2 (32.8)
Rfree, %a,d,e 26.8 (35.2) 27.5 (40.2)
Number of protein atoms 11,794 11,825
Number of water atoms 795 329
Number of other atoms 240 224
Rmsd bond length, Å 0.006 0.007
Rmsd bond angles, ° 1.32 1.18
Luzzatti error, Å 0.28 0.33
Average B factor, Å2
Protein overall 31.8 27.1
Protein main chain 31.1 26.8
Protein side chain 32.5 27.5
Water 35.5 18.8
Others 50.3 42.3
Ramachandran plot
Most favored, % 88.6 83.8
Additionally allowed, % 10.2 14.9
Generously allowed, % 0.8 0.8
Disallowed, % 0.5 0.5
a Values in parentheses are for the highest resolution shell.
b Numbers in parentheses are for the unique reflections.
c Rsym = Σ|I − <I>|/Σ<I>, where I is the observed intensity, and <I> is the average intensity of multiple observations of symmetry-related
reflections.
d R = Σhkl||Fobs| − |Fcalc||/Σhkl|Fobs|.
e Rfree is calculated from 10% of the reflections excluded from refinement.proteins with bound biphenyl-containing compounds, b
sthe dihedrals vary from 10° to 53°, suggesting that
the ring-ring dihedral of the biphenyl group in the o
mCD4M33:gp120 complex is not highly unfavorable.
However, the observed orientation of the first ring of c
dthe biphenyl moiety (chi1 −74°/−64°, chi2 −48°/−59°)
was more than 10° different from those of the Phe43 of t
sCD4 (chi1 −55°, chi2 −67°) (Figure 2B). This difference
in orientation suggested that to accommodate the bi-
aphenyl moiety, the biphenyl side chain and neighboring
atoms adopt an orientation that sacrifices mimicry. o
c
tF23 Structure in Complex with HIV-1 Core gp120
To investigate the effects of the rigid biphenyl and to c
increase mimicry, we synthesized a modified CD4M33,
with the biphenyl side chain of residue 23 replaced with t
Ca simple phenyl ring (Figure 2A). This modified mole-
cule, F23, partially reverts to previous generations of 0
sthe scorpion-toxin mimetic, for example, CD4M9,
which contained a Phe at this position (Vita et al., 1999). C
lWe were able to crystallize F23 in a similar P21 lattice
as the parent CD4M33. Refinement with 20–2.20 Å data c
dproduced an R value of 20.9% with an Rfree of 26.8%
(Table 1). Because of lattice symmetry, we were able to d
use difference fourier analysis to highlight differencesetween the CD4M33 and F23 complexes (Figure S1;
ee the Supplemental Data available with this article
nline). Difference fourier peaks clustered toward the
imetic:gp120 interface. The highest peaks were asso-
iated with the second phenyl ring of the biphenyl ad-
uct. Overall, difference fourier analysis indicated that
he CD4M33 and F23 complexes were extremely
imilar.
In terms of a comparison between the CD4, CD4M33,
nd F23 complexes, Figure 2B shows that substitution
f the CD4M33 biphenyl side chain with a phenyl side
hain enhanced mimicry of CD4 at this particular posi-
ion. We asked whether this increased ligand mimicry
ould be detected in the gp120 structure.
Superposition of the YU2 gp120 molecules from the
wo asymmetric units of F23 with the YU2 gp120 in the
D4 ternary complex gave overall Cα rms deviations of
.87/0.85 Å (Table 2). These superpositions were not
ignificantly different than those observed with
D4M33 (0.89/0.88 Å). Much of the overall deviation re-
ates to intrinsic gp120 flexibility, especially in the core-
eptor binding region, coupled to lattice variation. In-
eed, overall Cα rms deviations show that YU2 gp120
iffers more between independent copies in the asym-metric unit (0.31–0.42 Å) than between lattice-equiva-
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759lent CD4M33 and F23 variants of the mimetic (0.26–
0.32 Å). The lattice influence on structure can be seen
with even the tightly folded mimetic; the helix-loop-
strand connection of CD4M33 is substantially different
between the two independent molecules in the asym-
metric unit (Figure 1C). A full matrix of superpositions,
both overall and of individual gp120 domains, is shown
in Table 2. These superpositions show that the confor-
mation of gp120 induced by both CD4M33 and F23 is
so similar to the conformation induced by CD4 that
overall measures of analysis, even when reduced to in-
dividual domains, could not easily distinguish ligand-
induced differences in gp120 conformation from lattice-
induced variation.
Localized Measures of Structural Mimicry: Distance-
Sorted Difference Distances, Localized Rms
Deviations, and Residue-Specific Contact Surfaces
In structure-based drug design, it is useful to quantify
changes in the target molecule, as opposed to the lead
compound, since lead compounds can vary greatly,
making comparisons difficult. Prompted by difficulties
in using overall rms deviations to distinguish ligand-
induced changes from lattice- or isolate-induced vari-
ation, we attempted other means to quantify such
changes in the gp120 target molecule.
Qualitatively, we could observe differences in gp120
outside of the binding interface. An example is shown
in Figure 2C, in which a water channel that forms be-
tween the bridging sheet and the inner domain of
gp120 is shown. This channel was initially highlighted
in the HXBc2 and YU2 core structures (Kwong et al.,
2000), and it is also the location of residues, which,
when mutated, affect the binding of the CD4-antago-
nist, BMS-378806 (Lin et al., 2003; Madani et al., 2004).
Comparison of the shape of the water channel in these
three complexes showed greater similarity between the
F23 and CD4 complexes than with the CD4M33 com-
plex. Such qualitative comparisons, however, have lim-
ited utility, and thus we sought quantitative means of
accessing structural similarity.
We observed that in the ligand (CD4, CD4M33, or
F23), lattice variation had a larger effect on regions fur-
ther from the interaction hotspot. Thus, with CD4
bound to gp120 in different lattices, the second domain
of CD4 shows greater variation than the first domain,
which interacts with gp120 (Kwong et al., 2000); with
the two asymmetric unit variants of either CD4M33 or
F23 bound to gp120, the α helix showed greater varia-
tion than the β strands, which interact with gp120 (Fig-
ure 2B). In light of these observations, we asked
whether localized quantifications, focused on the in-
teraction hotspot, might be less influenced by lattice
variation and thus might be more revealing.
Several types of localized quantification were carried
out. We used rms deviation, restricted to the sphere or
shell surrounding the interaction hotspot (Figure 3). We
also complemented the rms deviation analysis with dif-
ference distance matrices (Nishikawa et al., 1972; Rich-
ards and Kundrot, 1988). These have the advantage of
being superposition independent and also being resi-
due specific. We modified these methods with distance
sorting to focus the difference distance matrix. We also
extracted overall summations of the difference distancematrix, by using either normalized linear summations or
rms of the matrix elements (Figure 2D). When restricted
to a 10 Å sphere centered on the Cα of the biphenyl
to phenyl change of CD4M33 to F23, “distance-sorted”
difference distance matrices of gp120 residues showed
F23 to emulate the structural change induced by CD4
significantly better then CD4M33 (Figure 2D). The im-
portance of using localized measures to reduce lattice
influences is demonstrated in Figure 3, in which a full
complement of distance-sorted difference distance
matrices (and associated rms deviations) have been
calculated with larger radial cutoffs.
Because of the high similarity (and small differences)
between the various gp120 structures, we analyzed the
role that coordinate error might play. This varies with
respect to resolution: the best structures (the F23 com-
plex at 2.2 Å resolution and the CD4:HXBc2core at
2.25 Å resolution) had Luzzatti estimated errors in coor-
dinate ofw0.3 Å; the more weakly diffracting structures
(the CD4M33 complex at 2.75 Å and the CD4:YU2core
at 2.9 Å) had estimated errors of about 20% greater.
These resolution-dependent overall estimated errors
were comparable to the observed rms deviations in Cα
positions between lattice-equivalent gp120 molecules
in the F23 and CD4M33 complex structures (0.26–
0.32 Å), but were substantially less than the differences
between lattice-nonequivalent structures (0.46–0.48 Å)
(Table 2). The fortuitous occurrence of CD4 structures
at low and high resolution, as well as of mimetic struc-
ture at low and high resolution, coupled to the presence
of two molecules in each of the mimetic asymmetric
units, allowed the influence of resolution-dependent
coordinate error to be decoupled (Figure 3). For exam-
ple, the upper right panel of Figure 3 shows that the
observed differences were similar between the two
asymmetric units of CD4M33 (at 2.75 Å) and F23 (at
2.2 Å). Thus, while resolution-dependent coordinate er-
ror does influence comparisons, the multiplicity of
structural information was able to control for some of
this resolution-dependent ambiguity.
Finally, we examined the residue-specific contacts of
gp120 and compare the interactive surface of gp120
with CD4, CD4M33, and F23 (Table 3). CD4 contacted
43 residues in YU2, 19 of which were not contacted by
either CD4M33 or F23. CD4M33 contacted 32 residues
(not including 2 residues with minor contacts observed
in only 1 of the 2 complexes in the P21 crystal), of which
9 were not contacted by CD4. F23 contacted 23 resi-
dues (not including 4 residues with minor noncon-
served contacts), all of which were also contacted by
both CD4 and CD4M33. Thus, although F23 had an
interface only half the size of CD4, all of the residues it
contacted were also contacted by CD4. In summary,
while overall rms deviations were not very revealing,
localized measures of analysis indicated that, in terms
of gp120 conformation and contact surface, F23 had a
higher degree of CD4 mimicry than did CD4M33.
Thermodynamic Analysis of CD4, CD4M33,
and F23 Binding to HIV-1 gp120
To extend our analysis of transplantation mimicry from
the static crystal structures to the binding process, we
measured the thermodynamics of 17b and gp120 bind-
ing for CD4, CD4M33, and F23 by using isothermal tit-
Structure
760Figure 2. F23 Mimics CD4 Better than CD4M33
(A) Sequences of CD4M33 and F23 aligned with CD4 and scyllatoxin. Residues in CD4M33 and F23 that have been changed from the scorpion
toxin scyllatoxin are highlighted in purple (CD4M33) and blue (F23), with cysteine residues highlighted in red. CD4 residues from the CDR2-
like loop (40–48) are highlighted in orange-yellow. Residues that interact with YU2 core gp120 are underlined. Secondary structure elements
from F23 and CD4 are shown above and below the sequences, respectively.
(B) Close-up of residue 43 of CD4 and of residue 23 of the CD4 mimetics. Left panel: The free structures of CD4 (orange-yellow; PDB
accession 1cdi, 1cdh, 1cdj, and 3cd4) are shown superimposed on the free NMR structure ensemble for CD4M33 (gray). Middle panel: The
bound structure of CD4 (orange-yellow) from the HXBc2 and YU2 core ternary complexes with Fab 17b (PDB accession 1rzj and 1rzk) are
shown superimposed on the two bound CD4M33 structures (purple) from the two ternary complexes in the P21 asymmetric unit. Right panel:
The bound structure of CD4 (orange-yellow) from the HXBc2 and YU2 core ternary complexes with Fab 17b are shown superimposed on the
two F23 structures (blue). The outlier CD4 bound structure is from the HXBc2-containing complex.
(C) Close-up of a gp120 water channel. These panels depict complexes with core YU2 gp120, with the left panel showing the CD4 complex
(orange-yellow), the middle panel showing the CD4M33 complex (purple), and the right panel showing the F23 complex (blue). The orientation
of these panels is similar to that shown in (B), with the molecular surface of gp120 extracted from the ternary complex shown in gray.
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761Table 2. Rms Deviations for Superpositions of Core gp120 Complexed with CD4, CD4M33, and F23
CD4/YU2 CD4/HXBc2 M33(1)/YU2 M33(2)/YU2 F23(1)/YU2 F23(2)/YU2
CD4/YU2 0.87 0.89 0.88 0.87 0.85
CD4/HXBc2 0.89 1.06 1.04 1.02 1.00
M33(1)/YU2 0.94 1.09 0.42 0.32 0.48
M33(2)/YU2 0.92 1.07 0.45 0.46 0.26
F23(1)/YU2 0.92 1.05 0.34 0.48 0.31
F23(2)/YU2 0.89 1.03 0.50 0.33 0.45
CD4/YU2 I 0.89 0.87 0.85 0.87 0.83
O 1.41 1.05 1.03 0.95 0.93
B 1.35 0.97 0.85 0.92 1.02
CD4/HXBc2 I 1.12 1.24 1.23 1.20 1.18
O 0.76 1.38 1.28 1.33 1.21
B 0.93 1.87 1.43 1.74 1.38
M33(1)/YU2 I 0.98 1.35 0.28 0.33 0.37
O 0.88 0.84 0.50 0.36 0.58
B 0.77 1.22 0.62 0.44 0.87
M33(2)/YU2 I 0.94 1.32 0.33 0.30 0.24
O 0.88 0.84 0.47 0.56 0.34
B 0.74 1.10 0.43 0.53 0.43
F23(1)/YU2 I 0.94 1.31 0.36 0.33 0.27
O 0.86 0.80 0.30 0.53 0.55
B 0.74 1.22 0.36 0.48 0.61
F23(2)/YU2 I 0.89 1.21 0.43 0.26 0.30
O 0.82 0.81 0.50 0.31 0.52
B 0.98 1.18 0.60 0.41 0.48
A matrix of rms deviations is shown for gp120 molecules from various complexes listed on the left and across the top of the table. CD4/YU2
refers to gp120 in the ternary complex of YU2 gp120 with two-domain CD4 and Fab 17b (PDB ID 1rzk), CD4/HXBc2 refers to gp120 in the
ternary complex of HXBc2 gp120 with two-domain CD4 and Fab 17b (PDB ID 1rzj), and the M33 and F23 complexes refer to the ternary
complexes described here, with “(1)” and “(2)” designating different gp120 molecules in the asymmetric unit. The top portion of the table
shows overall gp120 rms deviations after superposition for main chain atoms (lower left, underlined numbers) and Cα atoms (upper right).
The bottom portion of the table shows gp120 domain rms deviations for Cα atoms after superposition of the outer domain of gp120 (lower
left) or the inner domain of gp120 (upper right). Residues used in the overall superposition were 89–126, 196–394, and 412–492 of core gp120,
with 9, 5, and 17 residues removed from the N terminus, the site of V1/V2 loop truncation, and the V4 loop, respectively. Main chain atoms
consisted of the backbone nitrogen, Cα, backbone carbon, and carbonyl oxygen. Residues used were 89–119, 204–255, and 475–492 for the
inner domain (I); 256–394, 412–422, and 436–474 for the outer domain (O); 120–126, 196–203, and 423–435 for the bridging sheet (B). Numbers
in italics report rms deviations for domains not involved in the superposition.be more biologically relevant than that of core gp120.showed the unusual enthalpy and entropy indicative of
(D) Distance-sorted difference distance matrices of gp120. The YU2 gp120 Cα distances (Å) from Phe43 of CD4 were sorted and are shown
along with the corresponding gp120 residue in the far-left column. Difference distance matrices composed of these gp120 residues were
calculated for various gp120 complexes with CD4, CD4M33, and F23. Each i,j matrix element shows the distance between atom i and atom
j in the first specified structure minus the distance between the same atoms in the second specified structure. The difference distance
matrices could be quantified by rms of the difference distances (“square”) or by linear summation of the absolute value of the difference
distance normalized by the number of matrix elements (“linear”). Both values are shown for nondiagonal matrix elements. The matrices show
both visually and quantitatively that the structural changes induced in gp120 by CD4 are more closely mimicked by F23 than CD4M33.
(Comparable rms deviations are given in Figure 3, with a full complement of distance-sorted difference distance matrices.)ration calorimetry (Table 4). One of the hallmarks of the
CD4-induced conformational change in gp120 is the
formation of the coreceptor binding site (Trkola et al.,
1996; Wu et al., 1996). The 17b antibody binds to the
coreceptor binding site, and, in the core context, its
affinity is highly dependent on the presence of CD4. Its
binding thus provides a measure of the conformational
change induced in gp120. The 17b bound core YU2
gp120 with a relatively large entropic change and low
affinity. Prior formation of the CD4:YU2core complex al-
tered 17b binding dramatically, with entropy decreasing
3-fold and affinity increasing w200-fold. This dramatic
alteration was also seen with 17b binding to the
CD4M33:YU2core, which showed extremely similar
thermodynamics (Table 4). Binding to core YU2 by CD4gp120 refolding observed previously, although the
overall entropic change was about 30% less than that
observed previously with full-length YU2 (Kwong et al.,
2002). Binding to core by CD4M33 or F23 showed sig-
nificantly lower entropies, about half the level of that
observed with CD4.
Because core gp120, which is only two-thirds the
size of full-length gp120, is missing significant portions
of functionally important regions (the N/C termini and
also the V1, V2, and V3 regions), we analyzed binding
to a full-length gp120, engineered to remove only the
V1/V2, which may sterically occlude the CD4 site. Un-
like core gp120, this V1/V2 gp120 is functionally active
for both receptor binding and virus entry (Cao et al.,
1997; Wyatt et al., 1993), and thus its behavior should
Structure
762Figure 3. Distance-Sorted Difference Distance Matrices for gp120 Complexed with CD4, CD4M33, and F23
Rms deviations and difference distance matrices provide overall and atom-specific quantifications of gp120 structural differences. To quantify
the CD4 or mimetic influence of gp120 structures, we focused on gp120 residues around the Phe43 hotspot of CD4 (or the equivalent position
in CD4M33 or F23). The 50 closest Cα positions of YU2 gp120 from Phe43 of CD4 were sorted and divided into three groups. These distances
and the corresponding gp120 residues are shown in the upper left of the figure. The rms deviations of main chain atoms (C, N, Cα) for each
group and for each pair of structures are shown. Difference distance matrix plots were calculated between structural pairs by using the
distance-sorted atoms; for each pair of structures, “1” and “2,” the difference distance D12 = |ai − aj|1 − |ai − aj|2 was calculated, where ai
and aj are the atomic positions for the Cα of residues i and j, respectively. Differences are colored in ten increments, between −1.0 Å (red)
and 1.0 Å (blue). The influence of lattice and isolate differences can be seen in the groups beyond 10 Å distance from Phe43. These obscure
the ligand-induced differences in gp120 due to differences in binding to CD4, CD4M33, or F23. For example, in the 10–13.5 Å shell, HXBc2
and YU2 bound to CD4 show an rms deviation of 0.32 Å, which is significantly larger than the HXBc2:CD4 versus YU2:F23 rms deviations of
0.28/0.24 Å. Such difficulties in discriminating lattice- and isolate-induced structural changes from ligand-specific ones highlight the utility of
focusing on structural hotspots with distance-sorted difference distance matrices to reveal important ligand-induced structural differences.
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763Table 3. Contact Surface Areas by Residue of gp120 for CD4, CD4M33, and F23 Complexes
CD4/HXBc2 CD4/YU2 CD4M33/YU2(1) CD4M33/YU2(2) F23/YU2(1) F23/YU2(2)
(821.8 A2) (874.1 A2) (527.6 A2) (543.1 A2) (363.8 A2) (398.0 A2)
YU2 Main Side Total Main Side Total Main Side Total Main Side Total Main Side Total Main Side Total
123 T 0.0 4.1 4.1
124 P 3.9 28.4 32.3 9.3 37.9 47.2 0.0 9.7 9.7 0.0 8.8 8.8 0.0 5.7 5.7 0.0 8.6 8.6
125 L 3.3 0.0 3.3 1.7 0.0 1.7
126 C 17.9 28.0 45.9 15.8 29.8 45.5
127 V 5.6 3.9 9.5 2.8 0.0 2.8
128 G 2.8 0.0 2.8 15.0 0.0 15.0
194 G 12.6 0.0 12.6
196 C 0.0 6.9 6.9 0.0 20.1 20.1
255 V 0.0 18.1 18.1 0.0 16.5 16.5
256 S 8.2 0.0 8.2 7.4 0.0 7.4
257 T 0.0 5.7 5.7 0.0 4.1 4.1 0.0 15.1 15.1 0.0 10.8 10.8 0.0 6.5 6.5 0.0 6.5 6.5
278 T 0.8 0.0 0.8
279 N 2.0 16.3 18.3 0.0 15.6 15.6
280 N 10.4 31.8 42.3 13.4 29.1 42.6 0.0 2.5 2.5 0.0 1.9 1.9 0.4 0.7 1.1 0.0 0.9 0.9
281 A 13.5 25.9 39.4 17.4 22.2 39.6 8.8 3.8 12.6 7.9 4.4 12.3 8.5 6.2 14.7 0.2 2.0 2.2
282 K 0.0 9.2 9.2 3.7 10.7 14.4
283 T 1.4 14.7 16.1 3.2 13.2 16.4 0.0 0.2 0.2
364 S 0.0 1.4 1.4 0.0 2.8 2.8 0.0 1.1 1.1 0.0 1.5 1.5
365 S 16.2 30.9 47.1 9.9 27.1 37.1 13.9 18.4 32.3 12.2 20.7 32.9 12.2 20.7 32.9 12.9 22.2 35.0
366 G 20.1 0.0 20.1 20.8 0.0 20.8 18.3 0.0 18.3 23.5 0.0 23.5 16.7 0.0 16.7 23.8 0.0 23.8
367 G 21.8 0.0 21.8 21.9 0.0 21.9 17.0 0.0 17.0 26.6 0.0 26.6 17.9 0.0 17.9 25.4 0.0 25.4
368 D 7.1 45.2 52.3 8.6 41.8 50.4 7.5 29.3 36.8 9.4 40.2 49.6 7.2 30.7 37.8 8.5 44.3 52.8
369 P 0.0 0.7 0.7
370 E 0.0 19.1 19.1 0.0 17.6 17.6 0.0 29.2 29.2 0.0 30.4 30.4 0.0 21.2 21.2 0.0 18.7 18.7
371 I 0.0 39.3 39.3 0.0 38.1 38.1 0.0 44.8 44.8 0.0 40.2 40.2 0.0 40.3 40.3 0.0 41.1 41.1
375 S 4.0 11.6 15.7 0.0 14.1 14.1
376 F 10.7 0.0 10.7 13.0 0.0 13.0
377 N 2.2 5.2 7.4 3.5 5.3 8.8
382 F 0.0 19.4 19.4 0.0 23.1 23.1
384 Y 0.0 9.0 9.0 0.0 7.4 7.4
424 I 0.0 9.8 9.8 0.0 7.9 7.9
425 N 6.5 20.3 26.8 7.7 24.0 31.6 9.7 11.4 21.1 11.3 11.1 22.4 6.6 9.0 15.5 5.5 9.9 15.4
426 M 13.8 0.0 13.8 12.7 0.0 12.7 15.3 0.0 15.3 15.4 0.0 15.4 14.8 0.0 14.8 13.9 0.0 13.9
427 W 18.2 12.3 30.5 15.5 10.2 25.7 20.2 22.0 42.2 17.2 22.1 39.3 16.4 9.3 25.6 19.2 8.3 27.5
428 Q 2.4 0.0 2.4 2.6 0.0 2.6 2.0 0.0 2.0 3.2 0.0 3.2 1.3 0.0 1.3 2.8 0.0 2.8
429 K 10.5 3.2 13.7 8.0 4.1 12.1 11.3 0.0 11.3 11.2 0.0 11.2 9.7 0.0 9.7 11.5 0.0 11.5
430 V 14.2 54.8 69.0 17.7 55.9 73.6 8.0 34.2 42.2 7.2 33.8 41.0 7.1 32.7 39.8 8.4 36.4 44.8
431 G 1.4 0.0 1.4 2.3 0.0 2.3 1.5 0.0 1.5 2.1 0.0 2.1 1.5 0.0 1.5 1.1 0.0 1.1
432 K 0.0 1.7 1.7 0.0 2.8 2.8
455 T 0.0 12.8 12.8 1.8 8.3 10.0 0.0 3.1 3.1 0.0 2.8 2.8 0.0 0.2 0.2 0.0 0.9 0.9
456 R 7.0 0.0 7.0 3.8 0.0 3.8
457 D 5.9 21.0 26.9 6.3 20.7 27.0 3.0 1.9 4.9 1.6 1.1 2.6 1.5 0.6 2.2 2.0 4.2 6.2
458 G 5.2 0.0 5.2 9.8 0.0 9.8 2.6 0.0 2.6 1.5 0.0 1.5
459 G 29.2 0.0 29.2 11.8 0.0 11.8
460 K 8.5 25.0 33.5 12.2 49.2 61.4
461 D 1.7 0.0 1.7 1.1 8.5 9.6
469 R 0.0 6.6 6.6 0.0 7.0 7.0 0.0 1.8 1.8
471 G 0.7 0.0 0.7 0.8 0.0 0.8
472 G 22.4 0.0 22.4 17.6 0.0 17.6 5.1 0.0 5.1 6.5 0.0 6.5 6.7 0.0 6.7 6.2 0.0 6.2
473 G 23.5 0.0 23.5 23.2 0.0 23.2 25.5 0.0 25.5 26.1 0.0 26.1 21.4 0.0 21.4 21.1 0.0 21.1
474 D 12.7 26.2 38.9 5.4 27.3 32.7 7.5 13.6 21.1 10.1 13.0 23.1 9.9 12.3 22.2 8.0 13.6 21.6
475 M 0.0 7.0 7.0 0.0 6.1 6.1 0.0 10.5 10.5 0.2 11.0 11.2 0.0 6.3 6.3 0.0 6.1 6.1
476 R 0.0 3.8 3.8 0.0 3.4 3.4
477 D 0.0 9.5 9.5 0.0 7.1 7.1
“Main,” “side,” and “total” refer to the surface area of the main chain atoms, the surface area of the side chain atoms, and the total surface
area for each gp120 residue specified. Residues are colored blue if they have a contact surface common to CD4, CD4M33, and F23, black if
the contact is not conserved, and red if the contact is unique to both independent copies of CD4M33 in the P21 crystal.We observed that CD4 binding to V1/V2 gp120
showed highly unusual enthalpic and entropic changes,
approaching −60 kcal/mol and 50 kcal/mol, respec-
tively. Interestingly, CD4M33 displayed changes of only
about two-thirds of this number, whereas F23 binding
displayed enthalpic and entropic changes very similar
to those observed with CD4, −58.6 versus −54.8 kcal/mol and 47.1 versus 45.6 kcal/mol, respectively, al-
though it had substantially lower affinity (Table 4). The
results suggested that the mimetics, CD4M33 and F23,
were both able to induce many of the same conforma-
tional changes in gp120 as CD4, especially with regard
to the portion of the coreceptor binding site bound by
17b. However, in terms of the more biologically relevant
Structure
764Table 4. Thermodynamics of Binding for 17b, CD4M33, F23, and Two-Domain CD4 to gp120
Isothermal Titration Calorimetrya
Ligand gp120 G (kcal/mol) H (kcal/mol) −TS (kcal/mol) KD (nM) N
17b Fabb YU2core −8.6 ± 0.1 −31.8 ± 0.8 23.2 ± 0.7 940 ± 160 0.9 ± 0.1
YU2core/CD4 −11.8 ± 0.4 −18.9 ± 0.9 7.1 ± 0.6 6 ± 3 0.8 ± 0.1
YU2core/CD4M33 −11.9 ± 0.1 −20.6 ± 0.1 8.7 ± 0.2 4 ± 1 0.8 ± 0.1
CD4 YU2core −10.6 ± 0.2 −43.8 ± 0.3 33.2 ± 0.4 39 ± 2 1.0 ± 0.1
CD4M33 −8.6 ± 0.1 −26.4 ± 1.4 17.8 ± 1.4 950 ± 150 1.0 ± 0.2
F23 −7.1 ± 0.1 −20.5 ± 1.3 13.4 ± 1.3 9480 ± 440 1.0 ± 0.1
CD4 YU2V1/V2 −11.5 ± 0.1 −58.6 ± 0.4 47.1 ± 0.4 9 ± 1 1.0 ± 0.1
CD4M33 −10.2 ± 0.1 −38.2 ± 1.5 28.1 ± 1.4 73 ± 16 1.1 ± 0.1
F23 −9.3 ± 0.1 −54.8 ± 2.7 45.6 ± 2.6 318 ± 7 0.9 ± 0.1
a Each experiment was repeated 2–5 times, and the numbers are shown as mean ± standard error.
b Experimental constraints limited the ability to measure 17b binding to additional complexes. For YU2core/F23, the weak affinity between
F23 and gp120 prevented accurate secondary ligand titration; with YU2V1/V2 complexes, the 17b affinity was subnanomolar, too tight to
be measured by titration calorimetry.V1/V2 gp120, F23 replicated the CD4-induced changes F
(in entropy and enthalpy more accurately than CD4M33.
a
tNeutralization Breadth of CD4, CD4M33,
and F23 on HIV-1, HIV-2, and SIVcpz w
CIn light of the structural and thermodynamic mimicry of
CD4 by CD4M33 and F23, we investigated the mimicry w
yof another unique property of CD4, the ability of soluble
CD4 to compete with cell surface CD4 and neutralize n
cdiverse isolates across the entire primate immunodefi-
ciency lentiviral family (Smith et al., 1987; Trkola et al., (
t1995). We explored the neutralization capacities of
CD4, CD4M33, and F23 with a panel of primate immu- c
fnodeficiency viruses ranging from clade B isolates all
the way to HIV-2 and SIVcpz (Table 5). Because primary i
gisolates vary in their sensitivity to soluble CD4 neutral-
ization (Daar and Ho, 1991; Moore et al., 1992), we nor-
malized for overall neutralization sensitivity by examin- M
Wing relative neutralization potency. This allowed us to
estimate the G of binding for CD4, CD4M33, and genetic distance could be fit linearly (Figure 4). Such an
Table 5. Viral Neutralization Capabilities of Soluble CD4, CD4M33, and F23
IC50 Genetic Distanceb
Virus Species CD4a, M (g/ml) CD4M33, M (g/ml) F23, M (g/ml) to HXBc2
NL4.3 env HIV-1 group M 0.003 (0.10) 0.004 (0.01) 0.013 (0.04) 0.05894
YU-2 env HIV-1 group M 0.012 (0.49) 0.150 (0.44) 1.023 (2.92) 0.15432
HOBR 13 HIV-1 group M 0.080 (3.25) 4.836 (14.16) 49.869 (142.28) 0.18859
MN-8 HIV-1 group M 0.001 (0.02) 0.031 (0.09) 0.085 (0.24) 0.19790
MN-25 HIV-1 group M 0.113 (4.60) 0.370 (1.08) 3.583 (10.22) 0.19596
SUMA d736-68 HIV-1 group M 0.002 (0.07) 0.002 (0.01) 0.028 (0.08) 0.19178
SUMA d736-68M HIV-1 group M 0.110 (4.46) 0.780 (2.28) 11.085 (31.62) 0.19026
SUMA d736-73 HIV-1 group M 0.091 (3.69) 0.844 (2.48) 8.486 (24.21) 0.19026
WEAU 16-8 HIV-1 group M 0.034 (1.40) 0.633 (1.85) 1.447 (4.13) 0.20045
WEAU 16-8M HIV-1 group M 0.001 (0.05) 0.058 (0.17) 0.133 (0.38) 0.20241
GAB-1 fl SIVcpz (P.t.t.) 0.005 (0.19) 0.233 (0.68) 0.351 (1.00) 0.43799
GAB-2 62 fl SIVcpz (P.t.t.) 0.024 (0.99) 0.325 (0.95) 1.018 (2.90) 0.47955
JOMA pbmc HIV-1 group O 0.045 (1.83) 32.270 (94.52) 27.930 (79.68) 0.58518c
7312A fl HIV-2 0.009 (0.35) 8.133 (23.82) 2.488 (7.10) 0.68205
UC2 Ns HIV-2 0.034 (1.38) 7.866 (23.04) 2.823 (8.05) 0.69647
UC1NsMf HIV-2 0.004 (0.15) 201.967 (591.56) 28.375 (80.95) 0.70650
a Virus isolates INME 1, TRJO 58, YBF30 pbmc, smM949, huM949 d28, and huM949 d40 were also tested, but they could not be neutralized
at 0.556 M, the highest concentration of soluble CD4 used.
b The genetic distance is the average amino acid change per residue.
c The sequence of JOMA pbmc is not known; the genetic distance was estimated by using the clade O consensus sequence from Los Alamos
National Laboratory HIV database and adding the average genetic distance (0.05943) between the consensus and the ten clade O isolates
used in forming the consensus.23, and we did so as a function of genetic distance
Figure 4). Such an analysis provides an isolate-
veraged estimate of the relative neutralization poten-
ial. For clade B viruses, similar to the HXBc2 isolate in
hich the initial mimetic design was carried out,
D4M33 was only 0.2 kcal/mol less effective than CD4,
hereas F23 was 1.9 kcal/mol less effective (Figure 4,
intercepts). These results, estimated directly from
eutralization potency, agree with the thermodynami-
ally observed G of binding to V1/V2 YU2 gp120
Tables 4 and 6). They show that the single phenyl ex-
ension of CD4M33 into the hydrophobic interfacial
avity enhances neutralization potency by roughly 10-
old. A similar extension on CD4 might lead to similarly
ncreased neutralization potency, but our results sug-
est that it might also lead to reduced breadth.
imicry as Defined by Neutralization Breadth
e observed that the change in GN as a function of
Crystal Structures of CD4 Mimetic and HIV-1 gp120
765Figure 4. Free Energy Difference of CD4, CD4M33, and F23 Binding as a Function of gp120 Genetic Distance
For a compound (n) with a binding constant of K(n) that inhibits virus at an IC50(n), there exists a function f(n) such that f(n) = IC50(n)/K(n). The
free energy, G, is equal to −RTln(K), and thus the difference in free energy for two inhibitors, n = 1 and n = 2, is G = G(1) − G(2) =
[−RTlnK(1)] − [−RTlnK(2)] = −RTln [K(1)/K(2)] = −RTln {[IC50(1)/f(1)]/[IC50(2)/f(2)]} = −RT ln {[IC50(1)/IC50(2)] [f(2)/f(1)]}. Although f(n) is dependent
on a number of different variables, such as temperature, viral assay, and overall neutralization sensitivity, when using the same assay,
normalizing with the same virus, and using inhibitors that work through the same mechanism, f(1) can approximate f(2), and G z −RT ln
[IC50(1)/IC50(2)] h GN. This relates the relative neutralization potency of CD4, CD4M33, and F23 (Table 5) to the difference in free energy
as a function of genetic distance. The vertical axis shows GN in units of kcal/mol, and the horizontal axis shows genetic distance in units
of average amino acid change per residue from HXBc2, the isolate used in the original scorpion toxin transplantation design. The y intercept
gives a normalized relative potency against clade B isolates like HXBc2, and the slope shows the change in relative potency as a function of
evolutionary distance. The variance of the function relates to strain-specific effects and also to how well f(1) approximates f(2). As expected,
the variance between the two mimetics is smaller than with CD4; nonetheless, the correlation coefficients (r) for all three functions are
reasonable (59%–86%). HIV-1 group M viral isolates are depicted with open circles, SIVcpz isolates with filled triangles, HIV-1 group O isolates
with open triangles, and HIV-2 isolates with filled circles.analysis provides an alternative means to judge mim-
icry. A perfect mimetic of CD4 would have a slope of
zero and a variance related to the error in measure-
ment. With HXBc2 as a reference, we observed for
CD4M33 versus CD4 a slope of 6.1 kcal/mol per
average amino acid change per residue, and we ob-
served for F23 versus CD4 a slope of 2.8, both with
similar variances (Figure 4). One can also compare F23
and CD4M33, independent of CD4; such quantification
indicates that F23 retains its relative potency across
evolutionarily diverse viral isolates better than
CD4M33, with F23 neutralizing HIV-2 strains, 7312A and
UC2, with IC50s of 7–8 g/ml and SIVcpz GAB strains
with IC50s of 0.3–1.0 g/ml (Table 5).
We investigated the effect of altering the choice of
evolutionary origin on the correlation of G as a func-
tion of genetic distance. The linear fit of GN was cal-
culated when either HIV-1 isolate YU2, SIVcpz isolate
GAB-1fl, or HIV-2 isolate UNC1NsMf were chosen as
evolutionary origins (Table 6). The slope and correlation
of the linear fit depend on the choice of isolate from
which the genetic distance is calculated, as each
choice of origin provides a different vantage point from
which to view the evolutionary landscape. The fit is only
linear to the extent that there is a linear correlation be-
tween an evolutionary direction and a particular ligand
feature. Nonetheless, we found that if YU2, HIV-2, or
SIVcpz isolates were chosen as origins, CD4M33 ver-
sus CD4 had, on average, twice the absolute slope as
F23 versus CD4 (Table 6). These results indicate that
the relative slope gives an indication of mimicry, even
if very different isolates are chosen as evolutionary ref-
erences.
Discussion
HIV utilizes a two receptor mechanism coupled to sub-
stantial gp120 refolding to maintain binding to host re-ceptors, while avoiding neutralization by antibody. Prior
to interaction with cell surface CD4, the viral spike is
protected by multiple mechanisms of evasion and is
highly resistant to antibody binding. Upon attachment
to CD4, gp120 undergoes a remarkable refolding (Chen
et al., 2005), and the spike becomes primed for interac-
tion (e.g., with coreceptor or with the drug Fuzeon), but
the close proximity of the target cell membrane re-
stricts antibody binding (Labrijn et al., 2003). Our re-
sults with the scorpion-toxin mimetics of CD4 suggest
that, once induced, the CD4 bound conformation of
gp120 is relatively stable. Even though thermodynamic
analysis indicated that F23 and CD4M33 induced only
half the entropic change in core gp120 as CD4, the ob-
served conformation of gp120 was virtually identical in
all three liganded structures. (Such similarity cannot be
attributed to 17b, as binding of 17b to both the YU2
core:CD4 and YU2 core:CD4M33 showed similar and
relatively small entropies of interaction.) The smaller in-
terfaces of the mimetic probably only stabilize a subset
of the CD4 interactions: significant entropy resides in
more distal regions until crystallization drives gp120 to
the observed conformation. Interestingly, much of the
conformational change between unliganded and CD4
bound gp120 occurs in the inner domain of gp120, but
neither CD4 nor F23 make direct contacts with it. With
F23, we find that less than 400 Å2 of interactive sur-
face—on the bridging sheet and outer domain—is suffi-
cient to snap the inner domain into its CD4 bound con-
formation.
The large conformational change induced by CD4 ex-
poses cryptic epitopes on gp120, which have been the
target of vaccine efforts (Fouts et al., 2002). The sim-
ilarity observed between F23-induced and CD4-induced
conformations of gp120 and the small size of F23 rela-
tive to CD4 suggest that F23:gp120 complexes may
have utility in this regard. The lower affinity of F23, how-
Structure
766Table 6. Effect of Choice of Evolutionary Origin on Calculations of GN as a Function of Genetic Distance
Origin
YU2 (HIV-1 GAB-1 fl UC1NsMf
clade B) (SIVcpz) (HIV-2) Average |Slope|
GN(CD4M33) − GN(CD4) slope 5.83 5.22 −6.20 5.75 ± 0.49
y intercept 0.47 −0.03 6.01
correlation coefficient 0.76 0.47 0.79
GN(F23) − GN(CD4) slope 2.41 2.61 −2.96 2.66 ± 0.28
y intercept 2.08 1.68 4.61
correlation coefficient 0.51 0.38 0.60
GN(CD4M33) − GN(F23) slope 3.41 2.61 −3.24 3.09 ± 0.42
y intercept −1.62 −1.71 1.39
correlation coefficient 0.88 0.46 0.80
Different isolates were chosen as the evolutionary origin, and the linear fit to GN was calculated for each as described in Figure 4. Slopes
(kcal/mol per average amino acid change per residue), y intercepts (kcal/mol), and correlation coefficients from these linear fits are shown.
The average |slope| represents the average of the absolute value of the slopes obtained from using each of the specified evolutionary origins
in linear GN fits. Because we measured the affinity of YU2 directly by isothermal titration calorimetry, we had an independent means of
judging the accuracy of the GN calculations. The thermodynamically measured G of binding to V1/V2 YU2 gp120 were 1.2 and 2.3
kcal/mol for CD4M33 and F23, respectively (Table 4), which agreed with the 0.5 and 2.1 kcal/mol isolate-averaged estimate (y intercept)
obtained by using YU2 as the evolutionary origin.ever, may necessitate immunization with covalently
linked complexes, and the thiopropionic N-terminal res- d
idue of the F23 N terminus would need to be replaced o
to facilitate genetic linkage. v
Our analysis defines two quantitative measures of a
mimicry, one based on structure, and the other based T
on evolutionary conservation of function. The distance- o
sorted difference distance matrices provide a superpo- t
sition-independent measure of mimicry that can be fo- s
cused on the appropriate interaction hotspot. The a
GN, meanwhile, permits an isolate-averaged esti- d
mate of the difference in free energy of binding as a s
function of genetic distance. These quantifications de- h
fine a structure-based strategy for enhancing mimetic p
breadth. The premise behind this strategy is that in- t
creased structural mimicry of evolutionarily conserved H
interactions should lead to an increase in neutralization
breadth. Because we define metrics for evaluating E
structural mimicry in the target molecule, comparative
analyses of diverse lead compounds are possible. S
PIn comparing CD4M33 with CD4 to create F23, we
Tfocused on increasing molecular mimicry at an interac-
ption hotspot and found that this resulted in a substan-
otial increase in neutralization breadth. However, within
e
the HIV-1 subset of viruses, F23 displayed substantially p
reduced neutralization potency. It remains to be seen p
whether our strategy can simultaneously increase both m
tbreadth and potency. The second ring of the biphenyl
tinduced structural alterations in gp120, reducing CD4
mimicry; if a different extension were used that main-
Ctained the CD4-induced conformation, our results sug-
Sgest that such an extension would better maintain both
Vpotency and mimicry. In terms of CD4M33 and F23,

there is considerable room for improvement, as the c
other important hotspot of CD4 involving the Arg59 salt v
bridge is not fully optimized. Many drugs, including a c
significant fraction of current HIV-1 therapeutics such s
0as protease and fusion inhibitors (reviewed in Matthews
bet al., 2004 and Wlodawer and Vondrasek, 1998), are
omimetic antagonists. Our results with CD4, CD4M33,
u
and F23 suggest that, once the relative breadths of s
neutralization are known, the structures of the different a
complexes themselves can be used to define the ap-
propriate target to emulate.By using atomic-level structural analysis, thermo-
ynamic characterization of binding, and assessment
f neutralization capacities with an evolutionarily di-
erse panel of viral isolates, our studies serve to define
nd quantify overlapping facets of molecular mimicry.
he binding surface transplantation or protein grafting
f CD4 onto a scorpion-toxin scaffold shows some of
he power of atomic-level structural design. Our studies
uggest that, when considering therapeutic breadth,
nalysis and quantification of molecular mimicry as
emonstrated by the F23 prototype described here
hould play an important role. Such considerations
ave increasing urgency in light of the need for thera-
eutics that are effective against the diverse isolates of
he developing world and the ever increasing diversity of
IV-1 (Coffin, 1995; Korber et al., 2001; Vidal et al., 2000).
xperimental Procedures
ynthesis of CD4 Mini-Protein, Protein Expression,
urification, and Complex Preparation
he CD4 mimetics, CD4M33 and F23, were synthesized by solid-
hase methods as described (Martin et al., 2000, 2003). Constructs
f HIV-1 envelope gp120 proteins, core YU2 and V1/V2 YU2, were
xpressed in Drosophila Schneider 2 lines, and the ternary com-
lexes of CD4 mimetics with core YU2 gp120 and Fab 17b were
repared as described (Kwong et al., 2000) substituting CD4 mi-
etics for two-domain CD4. The addition of 0.1 M CD4 mimetic
o the gel filtration column buffer helped to stabilize formation of
ernary complexes during gel filtration purification.
rystallization, X-Ray Data Collection,
tructure Determination, and Refinement
apor-diffusion hanging-drop crystallizations were used, with 0.5
l protein solution (4–7 mg/ml in 0.35 M NaCl, 5 mM Tris [pH 7.1])
ombined with 0.5 l 0.3 M Gly-Gly-Gly tripeptide and 0.5 l reser-
oir solution of 14% PEG 4000, 14% isopropanol, 0.07 M sodium
itrate (pH 5.6) (70% of Crystal Screen reagent 40, Hampton Re-
earch) with 5 M NaCl added to the reservoir to a concentration of
.35 M after the crystallization droplet had been set up to counter
alance the NaCl in the protein solution. Crystals were crosslinked
ver a 20 l sitting droplet of 1.5% glutaraldehyde for 45 min by
sing the procedure of Lusty (1999), transferred to a cryoprotectant
olution containing the reservoir solution with 20% ethylene glycol
nd 10% 2R, 3R-butanediol for 1–2 min, and flash cooled to 100K° for data collection. X-ray data were collected at a wavelength
of 1.00 Å and were processed and reduced with HKL2000 (Otwi-
Crystal Structures of CD4 Mimetic and HIV-1 gp120
767nowski and Minor, 1997). The structure of CD4M33:YU2core:Fab
17b was solved by molecular replacement with AMoRe (Navaza,
1994) as implemented in the CCP4 package (CCP4, 1994). The
structure of core YU2 gp120 bound to Fab 17b in the 1G9N coordi-
nates was used as a search model, with the solution yielding a
Patterson correlation coefficient (10–4 Å data) of 48.3%. The den-
sity for the CD4M33 was clear after rigid body refinement of core
gp120 and Fab 17b, and the free structure of CD4M33 as deter-
mined by NMR was used as the starting point for further refine-
ment. Using programs O for model building (Jones et al., 1991) and
CNS for refinement (Brünger et al., 1998), side chains on the initial
models were corrected, and the models were subjected to torsion-
angle-simulated annealing with slow cooling, iterative manual fit-
ting, automated water placement, and positional and individual iso-
tropic B factor refinements. Noncrystallographic symmetry re-
straints were used in the initial stages of the refinement, but then
removed when it became clear that lattice effects caused substan-
tial structural differences. An Rfree test set consisting of 10% of the
data was used as a monitor throughout the refinement. The crystals
of F23:YU2core:Fab 17b were isomorphous to those of CD4M33:
YU2core:Fab 17b; its structure was solved by using the CD4M33
ternary complex as a starting model. Refinement was carried out
as described for the CD4M33 complex.
Model Analysis
All superpositions were performed by using lsqkab in CCP4 (CCP4,
1994) or lsqman in the Uppsala software package (Kleywegt, 1996).
Molecular surface interactions were calculated by using MS (Con-
nolly, 1993). Figures were prepared by using PyMOL (DeLano, 2002)
or GRASP (Nicholls et al., 1991). Difference distance matrices were
produce by distance sorting Cα positions and plotting with the pro-
gram DDMP (Fleming, 2004).
Isothermal Titration Calorimetry
Proteins were gel filtration purified (Superdex 200, Amersham Bio-
sciences) and dialyzed in PBS buffer (10 mM phosphate, 150 mM
NaCl [pH 7.4]). Experiments were conducted on a MicroCal VP-ITC
at 37°C, and data were analyzed with Origin software (MicroCal).
Core YU2 (1.5–24 M) and V1/V2 YU2 (1.0–6.5 M) were titrated
with CD4, CD4M33, F23, or 17b Fab by using 20–30 injections of
5–10 l per injection. Mimetic concentrations were determined by
quantitative amino acid analysis. Protein concentrations were de-
termined by absorbance at 280 nm based on extinction coefficients
calculated from the protein sequences.
Neutralization Assay and Data Analysis
Viral assays testing the neutralization capacity of CD4, CD4M33,
and F23 were carried out as described previously (Wei et al., 2003).
Protein sequences were used to build a phylogenetic tree by using
the parsimony method as implemented in PHYLIP (Felsenstein,
2004).
Supplemental Data
Supplemental Data including a description of difference fourier
analyses of CD4M33 and F23 complexes are available at http://
www.structure.org/cgi/content/full/13/5/755/DC1/.
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